WCRI Report – Physician Dispensing – Increases in Cost and Frequency in Workers’ Compensation

On July 19, WCRI (Workers’ Compensation Research Institute)  released its most recent study on the rapid growth of physician-dispensed pharmaceuticals for injured workers under state workers’ compensation.   The study compares 23 states, including Arkansas, Connecticut, Florida, Illinois, Indiana, Iowa, Louisiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina, Pennsylvania, Virginia, and Wisconsin highlighting changes in patterns of dispensing, […]...Read more

Christy Weir, RN, Joins Tower MSA Partners as Regional Vice President

Tower MSA Partners is pleased to introduce Christy Weir as the newest addition to its national sales team for Medicare Secondary Payer services. A native of Atlanta, Georgia, Christy will be responsible for both southeast regional and national accounts for Medicare Set Aside and Medicare Secondary Payer  compliance services.   Christy has more than 15 years experience in providing cost […]...Read more

Lyrica Approved for Spinal Neuropathic Pain – What Are the MSA Implications if Pfizer Extends Patent?

On June 21, 2012, the Food and Drug Administration announced its approval of Lyrica for use in the management of neuropathic pain associated with chronic, debilitating spinal cord injuries. Lyrica, the brand name for pregabalin, is manufactured by Pfizer (NYSE: PFE) and is already widely used to treat fibromyalgia pain. Prevalence of SCI Associated Neuropathic Pain According to […]...Read more